expands capabilities Pace Analytical has broadened its service footprint beyond environmental testing into life sciences support, regulatory consulting, lab instrument services, and staffing augmentation, signaling cross-selling opportunities with pharma, biotech, and contract development organizations.

recent expansions Recent investments include acquiring two life sciences laboratories and hiring new leadership in 2025–2026, indicating growth momentum and increased capacity to support larger client programs and more complex testing needs.

new methodologies The launch of ultrashort-chain PFAS testing demonstrates ongoing R&D and capability expansion, presenting a potential entry point for clients facing emerging environmental and regulatory challenges requiring advanced analytics.

strategic partnerships Partnership with Aspire Biolabs for drug-excipient compatibility and formulation work expands Pace’s appeal to pharmaceutical manufacturers needing comprehensive laboratory and regulatory support through the development lifecycle.

leadership signals Recent appointments of a new CEO and a Director of R&D indicate a strategic push toward scaling operations, formalizing processes, and pursuing larger, enterprise-level contracts across environmental and life sciences sectors.